Suppy and demand. Limit supply, increase price.
The main force keeping GTCB's price down is that whenever an increase in demand is threatened, like after EMEA approval, GTCB dumps an additional supply of shares on the market.
This is very simple economics; the law of supply and demand. As soon as the supply of shares becomes limited the price of the shares will start to increase.
Effectively, the management is competing against the shareholders. If management wouldn't keep selling additional shares, potential investors would have to buy shares on the market which would increase the price.
Why should significant investors buy shares on the market, pushing up the price, if they can rightly assume that they only have to wait a few months to buy shares from the company at depressed prices. But if the share supply is limited, potential investors will be motivated to line up to buy at current prices before it goes up.
We have an approved drug and the stock is selling for less than pre-approval. Why? Because the company keeps selling massive amounts of shares.
We have the opportunity to limit supply to 100,000,000 shares in May. Approving a 200,000,000 share supply will certainly act to keep the share price surpressed. Potential investor will know that they only have to wait till October to be able to buy another 10,000,000 shares when the management is ready to sell again.
The stock can be very valuable if the continued flooding of the market with additional shares can be stopped. And we shareholders have the opportunity to stop it now.
AI
